CVE-2019-15931

9.8 criticalEPSS 2.7%

Critical (9.8) in intesync solismed. EPSS 2.7% chance of exploitation in the next 30 days.

Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.

Severity

9.8 critical

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS: 2.7% chance of exploitation in the next 30 days; higher than 86% of CVEs (scores of 2026-10-31)
CWE: CWE-22
Published: 2019-12-12
Modified: 2026-06-17
Record from: the NVD, synced 2026-10-19